TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
XLO

Xilio Development Inc

Healthcare · Biotechnology

9.00$ +0.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XLO
Line item 2019 2020 2021 2022 2023 2024 2025
– -42.1% +510.2% -37.2% -56.2% +16.7% +117.6%
– -59.7% +883.6% -38.5% -61.3% +25.2% +140.8%
– -60.6% +929.5% -39.2% -62.9% +23.7% +148.7%
– -60.6% +929.5% -39.2% -62.9% +23.7% +148.7%
– – – -32.1% – – –
– +38.5% -0.6% -46.6% – – –
– +71.8% -13.1% -7.3% -28.1% +121.9% +123.3%
– +325.5% -42.3% +65.3% -24.4% +70.8% +106.4%
– – -70.4% +759.0% -42.5% -72.8% +13.0%
– +116.2% -42.2% -0.6% -66.4% +145.1% +23.1%
– -22.9% +29.9% -67.1% – – –
– -113.7% – -43.0% -65.1% -52.2% +100.4%
– – – – – – –
– +28.0% +970.3% +6,740.3% -92.8% +94.6% +2,087.0%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?